SYSTEMATIC REVIEW
Published on 07 Oct 2025
Evaluation of the efficacy and treatment-emergent adverse events of deuruxolitinib for moderate to severe alopecia areata: a dose-ranging meta-analysis of 1,372 randomized patients
doi 10.3389/fmed.2025.1641245
- 718 views